Abstract
Prosthetic valve thrombogenicity and bleeding complications associated with life-long anticoagulation are constant potential causes of morbidity and mortality following prosthetic valve implantation. The conflict between over- and under-anticoagulation is even more of a problem when other surgical interventions are required. Very few clinical trials have addressed this issue. We propose some guidelines based on the concept of risk-adjusted intensity of anticoagulation but stress the need for caution with interpretation of these recommendations.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Acar J., Enriquez-Sarano M., Farah E., Kassab R., Tubiana P., Roger V. Recurrent systemic embolic events with valve prosthesis. Eur Heart J. 1984 Oct;5 (Suppl 500):33–38. doi: 10.1093/eurheartj/5.suppl_d.33. [DOI] [PubMed] [Google Scholar]
- Acar J. Thromboembolic events in prosthetic valve recipients: what is the safe level of anticoagulation? J Heart Valve Dis. 1993 Jul;2(4):395–397. [PubMed] [Google Scholar]
- Altman R., Boullon F., Rouvier J., Raca R., de la Fuente L., Favaloro R. Aspirin and prophylaxis of thromboembolic complications in patients with substitute heart valves. J Thorac Cardiovasc Surg. 1976 Jul;72(1):127–129. [PubMed] [Google Scholar]
- COULSHED N., EPSTEIN E. J., WALKER E., GALLOWAY R. W. SYSTEMIC EMBOLISM IN MITRAL STENOSIS. Br Med J. 1964 Nov 28;2(5421):1393–1394. doi: 10.1136/bmj.2.5421.1393-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edmunds L. H., Jr Thrombotic and bleeding complications of prosthetic heart valves. Ann Thorac Surg. 1987 Oct;44(4):430–445. doi: 10.1016/s0003-4975(10)63816-7. [DOI] [PubMed] [Google Scholar]
- Horstkotte D., Schulte H., Bircks W., Strauer B. Unexpected findings concerning thromboembolic complications and anticoagulation after complete 10 year follow up of patients with St. Jude Medical prostheses. J Heart Valve Dis. 1993 May;2(3):291–301. [PubMed] [Google Scholar]
- Katholi R. E., Nolan S. P., McGuire L. B. The management of anticoagulation during noncardiac operations in patients with prosthetic heart valves. A prospective study. Am Heart J. 1978 Aug;96(2):163–165. doi: 10.1016/0002-8703(78)90080-7. [DOI] [PubMed] [Google Scholar]
- Saour J. N., Sieck J. O., Mamo L. A., Gallus A. S. Trial of different intensities of anticoagulation in patients with prosthetic heart valves. N Engl J Med. 1990 Feb 15;322(7):428–432. doi: 10.1056/NEJM199002153220703. [DOI] [PubMed] [Google Scholar]
- Shetty H. G., Woods F., Routledge P. A. The pharmacology of oral anticoagulants: implications for therapy. J Heart Valve Dis. 1993 Jan;2(1):53–62. [PubMed] [Google Scholar]
- Tinker J. H., Tarhan S. Discontinuing anticoagulant therapy in surgical patients with cardiac valve prostheses. Observations in 180 operations. JAMA. 1978 Feb 20;239(8):738–739. [PubMed] [Google Scholar]